• English
  • 简体中文
Login Register
Current Location: Home > Feedback Help Print

【结 构 式】

【分子编号】58719

【品名】2-({[(tert-butoxycarbonyl)(hydroxy)amino]carbonyl}oxy)-2-methylpropane

【CA登记号】

【 分 子 式 】C10H19NO5

【 分 子 量 】233.2646

【元素组成】C 51.49% H 8.21% N 6% O 34.29%

与该中间体有关的原料药合成路线共 3 条

合成路线1

该中间体在本合成路线中的序号:(III)

Sequential introduction of two tert-butoxycarbonyl groups into O-benzyl hydroxylamine (I) afforded the di-Boc-protected hydroxylamine (II). The O-benzyl group was then removed by hydrogenolysis over Pd/C yielding intermediate (III).

1 Koster, W.H.; Sundeen, J.E.; Straub, H.; Ermann, P.H.; Treuner, U. (Bristol-Myers Squibb Co.); Heteroaroyl derivs. of monocyclic beta-lactam antibiotics. EP 0484881; JP 1992283579 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 14640 O-benzylhydroxylamine; 1-[(aminooxy)methyl]benzene 622-33-3 C7H9NO 详情 详情
(II) 58718 1-({[bis(tert-butoxycarbonyl)amino]oxy}methyl)benzene C17H25NO5 详情 详情
(III) 58719 2-({[(tert-butoxycarbonyl)(hydroxy)amino]carbonyl}oxy)-2-methylpropane C10H19NO5 详情 详情

合成路线2

该中间体在本合成路线中的序号:(III)

Quinoxaline (VI) was prepared by condensation of phenylenediamine (IV) with tert-butyl 2,3-dioxobutyrate (V). Radical bromination of (VI) using N-bromosuccinimide and AIBN furnished the bromomethyl quinoxaline (VII) as the major brominated compound. This was condensed with N,N-di-Boc-hydroxylamine (III) to afford the protected O-alkyl hydroxylamine (VIII). Then, treatment of (VIII) with hot concentrated HCl gave rise to the fully deprotected quinoxaline (IX).

1 Koster, W.H.; Sundeen, J.E.; Straub, H.; Ermann, P.H.; Treuner, U. (Bristol-Myers Squibb Co.); Heteroaroyl derivs. of monocyclic beta-lactam antibiotics. EP 0484881; JP 1992283579 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(III) 58719 2-({[(tert-butoxycarbonyl)(hydroxy)amino]carbonyl}oxy)-2-methylpropane C10H19NO5 详情 详情
(IV) 58720 2,2-dimethyl-1,3-benzodioxole-5,6-diamine; 6-amino-2,2-dimethyl-1,3-benzodioxol-5-ylamine C9H12N2O2 详情 详情
(V) 58721 tert-butyl 2,3-dioxobutanoate C8H12O4 详情 详情
(VI) 58722 tert-butyl 2,2,7-trimethyl[1,3]dioxolo[4,5-g]quinoxaline-6-carboxylate C17H20N2O4 详情 详情
(VII) 58723 tert-butyl 7-(bromomethyl)-2,2-dimethyl[1,3]dioxolo[4,5-g]quinoxaline-6-carboxylate C17H19BrN2O4 详情 详情
(VIII) 58724 tert-butyl 7-({[bis(tert-butoxycarbonyl)amino]oxy}methyl)-2,2-dimethyl[1,3]dioxolo[4,5-g]quinoxaline-6-carboxylate C27H37N3O9 详情 详情
(IX) 58725 3-[(aminooxy)methyl]-6,7-dihydroxy-2-quinoxalinecarboxylic acid C10H9N3O5 详情 详情

合成路线3

该中间体在本合成路线中的序号:(III)

In an alternative route to the title compound, dinitro derivative (XV) was converted into the benzofuroxan (XVI) by treatment with sodium azide in hot DMSO. Furazan ring opening by means of tert-butyl acetoacetate (XVII) under basic conditions generated the quinoxaline N,N'-dioxide (XVIII). The Pummerer-like rearrangement of the N-oxide (XVIII) in the presence of trifluoroacetic anhydride gave rise to the unstable trifluoroacetoxymethyl quinoxaline (XIX), which was further converted to bromide (XX) upon heating with LiBr in acetone. Alkylation of N,N-di-Boc-hydroxylamine (III) with bromide (XX) provided the protected O-alkyl hydroxylamine (XXI). Reduction of the remaining N-oxide group of (XXI) and simultaneous N-Boc groups cleavage by means of boron tribromide furnished quinoxaline (XXII). The fully deprotected quinoxaline (IX) was then obtained by acidic treatment of (XXII). Condensation of keto amide (XIII) with hydroxylamine (IX) in the presence of tetrabutylammonium bisulfate produced the oxime adduct (XXIII). Finally, the title compound was obtained by deformylation of (XXIII) under acidic conditions.

1 Koster, W.H.; Sundeen, J.E.; Straub, H.; Ermann, P.H.; Treuner, U. (Bristol-Myers Squibb Co.); Heteroaroyl derivs. of monocyclic beta-lactam antibiotics. EP 0484881; JP 1992283579 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(III) 58719 2-({[(tert-butoxycarbonyl)(hydroxy)amino]carbonyl}oxy)-2-methylpropane C10H19NO5 详情 详情
(IX) 58725 3-[(aminooxy)methyl]-6,7-dihydroxy-2-quinoxalinecarboxylic acid C10H9N3O5 详情 详情
(XIII) 58728 N,N,N-tributyl-1-butanaminium (2R,3S)-3-({2-[2-(formylamino)-1,3-thiazol-4-yl]-2-oxoacetyl}amino)-2-methyl-4-oxo-1-azetidinesulfonate C26H45N5O7S2 详情 详情
(XV) 58730 2,2-dimethyl-5,6-dinitro-1,3-benzodioxole C9H8N2O6 详情 详情
(XVI) 58731 6,6-dimethyl[1,3]dioxolo[4,5-f][2,1,3]benzoxadiazol-1-ium-1-olate C9H8N2O4 详情 详情
(XVII) 27907 Acetoacetic acid tert-butyl ester;3-Oxo-butanoic acid 1,1-dimethylethyl estertert-butyl 3-oxobutanoate 1694-31-1 C8H14O3 详情 详情
(XVIII) 58732 6-(tert-butoxycarbonyl)-2,2,7-trimethyl[1,3]dioxolo[4,5-g]quinoxaline-5,8-diium-5,8-diolate C17H20N2O6 详情 详情
(XIX) 58733 6-(tert-butoxycarbonyl)-2,2-dimethyl-7-{[(2,2,2-trifluoroacetyl)oxy]methyl}[1,3]dioxolo[4,5-g]quinoxalin-5-ium-5-olate C19H19F3N2O7 详情 详情
(XX) 58734 7-(bromomethyl)-6-(tert-butoxycarbonyl)-2,2-dimethyl[1,3]dioxolo[4,5-g]quinoxalin-5-ium-5-olate C17H19BrN2O5 详情 详情
(XXI) 58735 7-({[bis(tert-butoxycarbonyl)amino]oxy}methyl)-6-(tert-butoxycarbonyl)-2,2-dimethyl[1,3]dioxolo[4,5-g]quinoxalin-5-ium-5-olate C27H37N3O10 详情 详情
(XXII) 58736 tert-butyl 7-[(aminooxy)methyl]-2,2-dimethyl[1,3]dioxolo[4,5-g]quinoxaline-6-carboxylate C17H21N3O5 详情 详情
(XXIII) 58737 di(N,N,N-tributyl-1-butanaminium) 3-({[((Z)-1-[2-(formylamino)-1,3-thiazol-4-yl]-2-{[(2R,3S)-2-methyl-4-oxo-1-sulfonatoazetidinyl]amino}-2-oxoethylidene)amino]oxy}methyl)-6,7-dihydroxy-2-quinoxalinecarboxylate C52H87N9O11S2 详情 详情
Extended Information